Literature DB >> 23036992

Two new de novo interstitial duplications covering 2p14-p22.1: clinical and molecular analysis.

J Kasnauskiene1, L Cimbalistiene, A Utkus, Z Ciuladaite, E Preiksaitiene, A Pečiulytė, V Kučinskas.   

Abstract

We provide a detailed clinical and molecular analysis of 2 patients with de novo interstitial duplications at 2p14-p16.1 and 2p16.1-p22.1. The 10.13-Mb duplication of chromosome 2p14-p16.1 was identified in a 9-year-old boy with mental retardation, behavioral problems (hyperactivity, hyperphagia, and subsequent vomiting), recurrent respiratory tract infections, macrocephaly, epilepsy, and dysmorphic features. The 17.49-Mb duplication of 2p16.1-p22.1 was found in a 17-year-old girl with moderate mental retardation, behavioral and emotional problems, anxiety, and facial dysmorphic features. Very few cases of de novo interstitial duplication of 2p14-p22.1 are reported in the literature, with the great majority of them lacking a detailed molecular analysis. The abnormal phenotype of these cases is caused by mechanisms such as the overdose of a duplicated gene (or genes), the disruption of a gene or its regulatory sequence by the breakpoints of duplication, or by an excess of genetic material which may disorganize chromatin conformation affecting distant gene expression. The clinical and molecular analysis of these 2 rare de novo interstitial duplications provides useful information which is extremely valuable for clinical evaluation at the prenatal and postnatal level and for the molecular understanding of the underlying mechanisms of human diseases.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23036992     DOI: 10.1159/000342544

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  2 in total

1.  A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58.

Authors:  Karina Lezirovitz; Gleiciele A Vieira-Silva; Ana C Batissoco; Débora Levy; Joao P Kitajima; Alix Trouillet; Ellen Ouyang; Navid Zebarjadi; Juliana Sampaio-Silva; Vinicius Pedroso-Campos; Larissa R Nascimento; Cindy Y Sonoda; Vinícius M Borges; Laura G Vasconcelos; Roberto M O Beck; Signe S Grasel; Daniel J Jagger; Nicolas Grillet; Ricardo F Bento; Regina C Mingroni-Netto; Jeanne Oiticica
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

2.  Considering specific clinical features as evidence of pathogenic copy number variants.

Authors:  Egle Preiksaitiene; Alma Molytė; Jurate Kasnauskiene; Zivile Ciuladaite; Algirdas Utkus; Philippos C Patsalis; Vaidutis Kučinskas
Journal:  J Appl Genet       Date:  2014-02-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.